@article{1037fefd468c46f5a4bbf483d8285803,
title = "Effectiveness of Pfizer-BioNTech mRNA Vaccination against COVID-19 Hospitalization among Persons Aged 12–18 Years — United States, June–September 2021",
abstract = "What is already known about this topic? Persons aged 12–18 years are eligible to receive COVID-19 vaccine. Currently, data are lacking on real-world vaccine effectiveness against COVID-19 hospitalization in adolescents. What is added by this report? Among hospitalized U.S. patients aged 12–18 years, vaccine effectiveness of 2 doses of Pfizer-BioNTech vaccine against COVID-19 hospitalization during June–September 2021, was 93% (95% confidence interval = 83%–97%). What are the implications for public health practice? This evaluation demonstrated that 2 doses of Pfizer-BioNTech vaccine were highly effective in preventing COVID-19 hospitalization among persons aged 12–18 years. Findings reinforce the importance of vaccination to protect U.S. youths against severe COVID-19.",
author = "{Overcoming COVID-19 Investigators} and Olson, {Samantha M.} and Newhams, {Margaret M.} and Halasa, {Natasha B.} and Price, {Ashley M.} and Boom, {Julie A.} and Sahni, {Leila C.} and Katherine Irby and Walker, {Tracie C.} and Schwartz, {Stephanie P.} and Pannaraj, {Pia S.} and Maddux, {Aline B.} and Bradford, {Tamara T.} and Nofziger, {Ryan A.} and Boutselis, {Benjamin J.} and Cullimore, {Melissa L.} and Mack, {Elizabeth H.} and Schuster, {Jennifer E.} and Gertz, {Shira J.} and Cvijanovich, {Natalie Z.} and Michele Kong and Cameron, {Melissa A.} and Staat, {Mary A.} and Levy, {Emily R.} and Chatani, {Brandon M.} and Kathleen Chiotos and Zambrano, {Laura D.} and Campbell, {Angela P.} and Patel, {Manish M.} and Randolph, {Adrienne G.}",
note = "Funding Information: All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. Natasha B. Halasa reports grants from Sanofi and Quidel outside of the submitted work. Jennifer E. Schuster reports grants from Merck outside of the submitted work. Pia S. Pannaraj reports grants from AstraZeneca and Pfizer outside of the submitted work, and personal fees from Seqirus and Nestle outside of the submitted work. No other potential conflicts of interest were disclosed. Publisher Copyright: {\textcopyright} 2021 Department of Health and Human Services. All rights reserved.",
year = "2021",
doi = "10.15585/MMWR.MM7042E1",
language = "English (US)",
volume = "70",
pages = "1483--1488",
journal = "Morbidity and Mortality Weekly Report",
issn = "0149-2195",
publisher = "Department of Health and Human Services",
number = "42",
}